Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

Contact Us

Search

Daiichi Sankyo

Onco_background

Oncology Weekly News - October 6th 2025

Oncology Update: Enhertu Superiority, Tecentriq Combo Approval, New Trials…

Women's_Health

Women's Health Latest News - Sept 17th to Sept 30th

Watch Our Video Summary Capturing Top Women's Health News from the Last Two…

Onco_background

Oncology Weekly News - September 29th 2025

Oncology Update: Vorasidenib Approval, Plixorafenib Efficacy, OPDIVO…

Onco_background

Oncology Weekly News - September 22nd 2025

Oncology Update: RGT-61159 Orphan Drug, CRB-701 Fast Track, PDS0101 Survival…

Categories

Obesity News
Endocrinology News
Our Insights
Immunology News
Case studies
Hematology News
BioPharma and Tech News
Oncology News
BioPharma Strategy, CI and AI Guides
Lucid Diligence Brief
Conference Social Media Reports
Venture Capital Trends
AI in Healthcare and Digital Health
Conference Previews
Cell and Gene Therapy News
Healthcare and Pharma Trends
Rare Disease News
Health Mobile Apps Reports
Neuroscience News
Women's Health News
Public Health News
Respiratory News
Cardiovascular News
Vaccine news

Recent Posts

Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery deal
Obesity Today—March 24, 2026
Endocrinology Today—March 24, 2026
Lucid Diligence Brief: Gilead Sciences to acquire Ouro Medicines
Oncology Today—March 23, 2026

Tags

CABG CAP-1002 CHIKV VLP Chronic disease mortality conduction-system pacing cost reduction CVS Pharmacy AI Screening DA-1726 DIPS Arena Enzalutamide Familial Drusen FDA Digital Health Advisory FG001 GLP-1 Receptor Agonists GNTI-122 gout flares HMPL-760 Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Hyperlipidaemia Jaypirca JUST-AAV licensing live biotherapeutic product Metsera MicroRNAs naxtarubicin Nemluvio noninvasive diagnostics obesity management OCALIVA POLY-ACS PPMS Pre-MIRACLE2 Rinvoq Rituximab Sangamo Therapeutics Sensitive Skin Research Spikevax Stanford Medicine Sutra Medical Tenacia Biotechnology TG Therapeutics Transgene Trevi Therapeutics Ver-A-T1D

Archives

Archives

1
2

LucidQuest Ventures

Accelerate Your Success

LATEST NEWS

Lucid Diligence Brief: Quotient and MSD ink a $2.2 billion IBD drug discovery deal
Obesity Today—March 24, 2026
Endocrinology Today—March 24, 2026
Lucid Diligence Brief: Gilead Sciences to acquire Ouro Medicines
Oncology Today—March 23, 2026

TAGS

CABG CAP-1002 CHIKV VLP Chronic disease mortality conduction-system pacing cost reduction CVS Pharmacy AI Screening DA-1726 DIPS Arena Enzalutamide Familial Drusen FDA Digital Health Advisory FG001 GLP-1 Receptor Agonists GNTI-122 gout flares HMPL-760 Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer Hyperlipidaemia Jaypirca JUST-AAV licensing live biotherapeutic product Metsera MicroRNAs naxtarubicin Nemluvio noninvasive diagnostics obesity management OCALIVA POLY-ACS PPMS Pre-MIRACLE2 Rinvoq Rituximab Sangamo Therapeutics Sensitive Skin Research Spikevax Stanford Medicine Sutra Medical Tenacia Biotechnology TG Therapeutics Transgene Trevi Therapeutics Ver-A-T1D

Consulting Services
For Investors
Products
Case Studies
Insights
BioPharma and Tech News

© 2026 LucidQuest Ventures. All rights reserved

We use cookies from third party services to offer you a better experience. Read about how we use cookies and how you can control them by clicking "Privacy Preferences".

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required

You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.

Privacy Policy